CH433314A - Verfahren zur Herstellung von Antibiotica - Google Patents

Verfahren zur Herstellung von Antibiotica

Info

Publication number
CH433314A
CH433314A CH1062762A CH1062762A CH433314A CH 433314 A CH433314 A CH 433314A CH 1062762 A CH1062762 A CH 1062762A CH 1062762 A CH1062762 A CH 1062762A CH 433314 A CH433314 A CH 433314A
Authority
CH
Switzerland
Prior art keywords
antibiotics
manufacture
Prior art date
Application number
CH1062762A
Other languages
English (en)
Inventor
Bennett Morin Robert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH433314A publication Critical patent/CH433314A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
CH1062762A 1961-09-11 1962-09-07 Verfahren zur Herstellung von Antibiotica CH433314A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13700061A 1961-09-11 1961-09-11

Publications (1)

Publication Number Publication Date
CH433314A true CH433314A (de) 1967-04-15

Family

ID=22475375

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1062762A CH433314A (de) 1961-09-11 1962-09-07 Verfahren zur Herstellung von Antibiotica

Country Status (4)

Country Link
BR (1) BR6242367D0 (de)
CH (1) CH433314A (de)
DE (1) DE1445685A1 (de)
GB (1) GB985747A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125838C (de) * 1965-11-24
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
US4492693A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
US4482553A (en) * 1983-04-12 1984-11-13 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
AU2673884A (en) * 1983-04-12 1984-10-18 Eli Lilly And Company Naphthylglycyl cephalosporin derivatives

Also Published As

Publication number Publication date
GB985747A (en) 1965-03-10
BR6242367D0 (pt) 1973-07-12
DE1445685A1 (de) 1968-12-05

Similar Documents

Publication Publication Date Title
CH420067A (de) Verfahren zur Herstellung von ortho-Alkylphenolen
CH412112A (de) Verfahren zur Herstellung von Festkörper-Kondensatoren
CH425813A (de) Verfahren zur Herstellung von Trialkalinitrilotriacetat
AT255031B (de) Verfahren zur Herstellung von 1-Glykosyl-6-azauracilen
CH433314A (de) Verfahren zur Herstellung von Antibiotica
CH407110A (de) Verfahren zur Herstellung von Fluorsteroiden
CH420186A (de) Verfahren zur Herstellung von 2-Amino-benzophenonen
CH416638A (de) Verfahren zur Herstellung von Spirobiphenylphenazametalloverbindungen
CH420185A (de) Verfahren zur Herstellung von 5-Mononucleotiden
AT239438B (de) Verfahren zur Herstellung von α-Aminobenzylpenicillin
AT241687B (de) Verfahren zur Herstellung von α-Aminobenzylpenicillin
CH420135A (de) Verfahren zur Herstellung von 16-Alkylpregnenen
CH420168A (de) Verfahren zur Herstellung von Sulfapyrimidinen
CH413836A (de) Verfahren zur Herstellung von Distilbazolen
CH419146A (de) Verfahren zur Herstellung von 3-Phenyl-7-pyrazolyl-cumarinen
CH438305A (de) Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
CH401026A (de) Verfahren zur Herstellung von B-Ketoamiden
CH446392A (de) Verfahren zur Herstellung von Diphenylalkanolaminen
CH439291A (de) Verfahren zur Herstellung von Thiazolosteroiden
CH394222A (de) Verfahren zur Herstellung von Bis-triazinylaminostilbenverbindungen
CH401949A (de) Verfahren zur Herstellung von 1-Alkyl-1-alkoxy-3-arylharnstoff
CH410932A (de) Verfahren zur Herstellung von 7a-Alkylthio-steroiden
CH404861A (de) Verfahren zur Herstellung von Antibiotika
CH412928A (de) Verfahren zur Herstellung von Tetrazoaminoverbindungen
CH416607A (de) Verfahren zur Herstellung von 19-Nor-steroidverbindungen